Thermo Fisher has agreed to buy Dutch diagnostics group Qiagen in a $11.5b deal, as the US scientific equipment maker expands its disease-testing capabilities amid the worsening coronavirus outbreak.
According to The Financial Times, the group, which has a market capitalisation of around $122bn and provides diagnostic tools, said buying the Dutch company would allow it to strengthen its portfolio, notably in testing for infectious diseases.
Qiagen is developing kits to test for Covid-19, which has infected more than 90,000 people globally and killed more than 3,000.
It previously provided testing equipment that was used during the Sars and swine flu outbreaks. Thermo Fisher had been reported to have had an interest in Qiagen before the coronavirus outbreak erupted.
In November, Qiagen, whose shares are listed in Frankfurt and New York, launched a strategic review to consider bids from various suitors before later saying it planned to go it alone.
“This acquisition provides us with the opportunity to leverage our industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs,” said Marc Casper, Thermo Fisher president and chief executive.
Qiagen has been working on equipment to detect Covid-19 since the outbreak began in January. Last week it said it had sent test kits to four hospitals in China for evaluation and plans to apply for emergency authorization to sell them in the US, Korea and China.
The kits, which provide test results in about an hour, are expanded versions of the company’s “QIAstat-Dx Respiratory Panel”, which is used to test for various other respiratory syndromes.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI